These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3819764)

  • 1. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
    Hoogenraad TU; Van Hattum J; Van den Hamer CJ
    J Neurol Sci; 1987 Feb; 77(2-3):137-46. PubMed ID: 3819764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
    Veen C; van den Hamer CJ; de Leeuw PW
    J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.
    Hoogenraad TU; Van den Hamer CJ; Van Hattum J
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):273-6. PubMed ID: 6430436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillamine hepatotoxicity in the treatment of Wilson's disease.
    Menara M; Zancan L; Sturniolo GC
    J Pediatr Gastroenterol Nutr; 1992 Apr; 14(3):353-4. PubMed ID: 1619543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Wilson's disease with Zincteral].
    Kuczyńska-Zardzewiały A; Rodo M; Członkowska A
    Neurol Neurochir Pol; 1988; 22(3):211-5. PubMed ID: 3221958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 10. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
    Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
    Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
    [No Abstract]   [Full Text] [Related]  

  • 11. Zinc therapy as the initial treatment for Wilson's disease.
    Hoogenraad TU; Van Hattum J
    Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.
    Hoogenraad TU; Rothuizen J
    Lancet; 1986 Jul; 2(8499):170. PubMed ID: 2873435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Wilson's disease].
    Hoogenraad TU; van Hattum J
    Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral zinc sulphate treatment in Wilson's disease.
    Pasqualicchio M; Marrella M; Moretti U; Velo GP; Deganello A; Tomelleri G; Milanino R
    Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
    Hartard C; Kunze K
    Eur Neurol; 1994; 34(6):337-40. PubMed ID: 7851456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
    Hill GM; Brewer GJ; Juni JE; Prasad AS; Dick RD
    Am J Med Sci; 1986 Dec; 292(6):344-9. PubMed ID: 3799705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.